Columbia Partners L L C Investment Management grew its stake in Monsanto (NYSE:MON) by 8.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 38,895 shares of the basic materials company’s stock after buying an additional 3,056 shares during the quarter. Columbia Partners L L C Investment Management’s holdings in Monsanto were worth $4,542,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Gradient Investments LLC purchased a new stake in Monsanto during the fourth quarter worth approximately $108,000. Americafirst Capital Management LLC purchased a new stake in Monsanto during the third quarter worth approximately $148,000. S&CO Inc. purchased a new stake in Monsanto during the third quarter worth approximately $216,000. McKinley Carter Wealth Services Inc. purchased a new stake in Monsanto during the fourth quarter worth approximately $218,000. Finally, Corundum Group Inc. purchased a new stake in Monsanto during the third quarter worth approximately $228,000. Institutional investors and hedge funds own 73.70% of the company’s stock.
Shares of Monsanto (NYSE:MON) opened at $120.42 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. Monsanto has a 52 week low of $111.80 and a 52 week high of $123.15. The firm has a market capitalization of $52,979.85, a P/E ratio of 20.98, a price-to-earnings-growth ratio of 1.72 and a beta of 1.01.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Thursday, April 5th. Monsanto’s dividend payout ratio is currently 39.85%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at $6,772,277.05. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.79% of the stock is currently owned by insiders.
Several research firms recently weighed in on MON. Wells Fargo & Co restated a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Royal Bank of Canada restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Finally, Zacks Investment Research cut Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $127.30.
COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://weekherald.com/2018/02/23/columbia-partners-l-l-c-investment-management-buys-3056-shares-of-monsanto-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.